Avicin G
Avicin G is a sphingomyelinase inhibitor and plasma membrane disruptor. Avicin G inhibits the enzymatic activities of neutral sphingomyelinases (SMPD2/3) and acid sphingomyelinase (SMPD1), elevates intracellular sphingomyelin levels, and alters the distribution of sphingomyelin. Avicin G interferes with the lateral segregation of GTP- and GDP-bound H-Ras, inhibits the signal output of oncogenic K-Ras and H-Ras, reduces the phosphorylation of ERK and Akt, increases lysosomal pH, and inhibits the endocytic recycling of epidermal growth factor receptor. Avicin G can be used in research related to pancreatic ductal adenocarcinoma and non-small cell lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 197787-17-0
- Formula: C98H155NO45
- Molecular Weight:2067.26
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Phospholipase Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Jurkat | IC50 |
0.22 μg/mL
Compound: 2, avicin G
|
Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
|
[PMID: 12828461] |
In Vitro
Avicin G (50-500 nM; 48 h) mislocalizes mGFP-K-RasG12V from the plasma membrane to endomembranes in MDCK cells with an IC50 of 73.8 nM after 48 h of treatment[1].
Avicin G (500 nM; 48 h) translocates mGFP-K-RasG12V from the plasma membrane to multiple endomembrane compartments including early endosomes, late endosomes, lysosomes, mitochondria, Golgi, and ER in MDCK cells, and increases the number and size of LAMP1-positive vesicles[1].
Avicin G (5-500 nM; 48 h) inhibits oncogenic Ras signal output by reducing phosphorylated ERK and Akt levels in MDCK cells expressing mGFP-K-RasG12V or mGFP-H-RasG12V, and increases mGFP-K-RasG12V expression levels[1].
Avicin G (1.25 μM; 4 days) inhibits the growth of KRAS-addicted human PDAC and NSCLC cell lines[1].
Avicin G (500 nM; 48 h) disrupts mGFP-K-RasG12V plasma membrane nanoclustering and the lateral segregation of GTP- and GDP-bound mGFP-H-RasG12V in BHK cells, contributing to reduced oncogenic Ras signal output[1].
Avicin G (5-1000 nM; 48 h) inhibits neutral sphingomyelinase activity with greater potency than acid sphingomyelinase activity in MDCK cells expressing mGFP-K-RasG12V, with significant inhibition of neutral SMase at ≥5 nM and acid SMase at ≥500 nM after 48 h of treatment[1].
Avicin G (5-1000 nM; 48 h) disrupts subcellular localization of SMPD1-GFP and SMPD2-GFP in MDCK cells, reduces SMPD1-GFP expression at ≥500 nM, increases SMPD2-GFP expression at ≥10 nM, and does not affect SMPD3-GFP expression or localization[1].
Avicin G (10-1000 nM; 48 h) increases lysosomal pH in a dose-dependent manner in WT MDCK cells, significantly elevating pH from 3.7 to 5.7 after 48 h of treatment with high concentrations[1].
Avicin G (100 nM; 48 h) inhibits endocytic recycling of EGFR-mGFP in CHO cells, causing accumulation of EGFR-mGFP in the perinuclear region instead of return to the plasma membrane[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDCK cells stably expressing mGFP-K-RasG12V or mGFP-H-RasG12V
-
Concentration:5 nM, 10 nM, 100 nM, 500 nM
-
Incubation Time:48 h
-
Result:Significantly reduced ppERK and pAkt levels in both K-RasG12V and H-RasG12V cells, with greater effects observed in K-RasG12V cells.
Significantly increased the expression level of mGFP-K-RasG12V, but not mGFP-H-RasG12V.
-
Cell Line:Human pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) cells
-
Concentration:1.25 μM
-
Incubation Time:4 days, with daily media replacement
-
Result:Significantly inhibited the growth of all tested K-Ras-addicted PDAC cell lines (AsPC-1, Panc10.05, MiaPaCa-2, HPAF-II, PANC-1) and K-Ras-addicted NSCLC cell lines (H358, H441).
-
Cell Line:MDCK cells stably expressing SMPD1-GFP, SMPD2-GFP, or SMPD3-GFP
-
Concentration:5 nM, 10 nM, 100 nM, 500 nM, 1000 nM
-
Incubation Time:48 h
-
Result:Disrupted the lysosomal localization of SMPD1-GFP and accumulated SMPD2-GFP in vesicular structures, but did not alter the PM localization of SMPD3-GFP.
Significantly reduced SMPD1-GFP expression at ≥500 nM.
Significantly increased SMPD2-GFP expression at ≥10 nM.
Did not change SMPD3-GFP expression.
Chemical Information
-
CAS No. 197787-17-0
-
Molecular Weight 2067.26
-
Formula C98H155NO45
-
SMILES
C=C[C@@](O)(C)CC/C=C(C)/C(O[C@@H]([C@H](O)[C@H]1O)[C@@H](C)O[C@H]1O[C@@](C)(C=C)CC/C=C(CO)/C(O[C@H]2C[C@]3(C(O[C@H]4[C@H](O[C@@H]5O[C@@H](C)[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](CO)O6)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@H]5O)[C@@H](O)[C@H](O)[C@@H](CO)O4)=O)[C@H](O)C[C@@]8(C)[C@]9(C)CC[C@@]%10([H])C(C)(C)[C@@H](O[C@H]%11[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@@H]%12O[C@H](C)[C@H](O)[C@H](O)[C@H]%12O[C@@H]%13OC[C@@H](O)[C@H](O)[C@H]%13O)O%11)NC(C)=O)CC[C@]%10(C)[C@@]9([H])CC=C8[C@]3([H])CC2(C)C)=O)=O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)